Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the inaugural CBIS Black-tie Gala has morphed into the Cannabis Science Awards Black-Tie Gala Ceremony that it should be. Still slated for Los Angeles, California, a possible pre-event mixer at one of the venues later this year, and realistically, the main Black-Tie Dinner Awards Gala will be slated for early next year. The Company is excited to commit to announcing the final list of events, venues, dates and times before the end of this year.
The Company has potential arrangements and offers now from a number of different types of venues, caterers, performers, and event public relations professionals including celebrities to help promote the event. The target goal is to raise the awareness and understanding of Cannabis Science and the appropriate clinical research to effect the change we want to see in clinical drug development programs for cannabinoids targeting critical ailments and palliative care.
Through its Black-Tie Awards Gala, Cannabis Science intends to celebrate the Company’s accomplishments in the medical-cannabis industry, along with those who have been instrumental in the Company’s achievements, namely its many partners, individuals and companies, its shareholders and key industry individuals are slated receive the Awards. The program for the Cannabis Science Black-tie Awards Gala will include cannabis treatment success stories from patients and physicians, live entertainment, fundraising auctions, and updates from the Company about new drug developments and future expansion plans. The Black-Tie Awards Gala will also showcase Cannabis Science’s new Pharmacies, and Mr. Raymond C. Dabney intends to award his loyalty shareholder gifts to shareholders at this event.
The Company is looking forward to creating a full day of events including conferences, workshops, mixers, and all cumulating to the Black-Tie Awards Dinner. This long-awaited event will be jointly hosted by Cannabis Science and some of its partners and will raise awareness and funds for increased proper clinical medical cannabis research to develop medicines to treat critical ailments such as various cancers, chronic pain, post-traumatic stress disorder (PTSD), neurological disorders, and many more.
“2018 has been an exciting year of major accomplishments for Cannabis Science and we have put in place a number of initiatives that we expect to contribute to our long-term growth and profitability,” stated Mr. Raymond C. Dabney, Cannabis Science Inc., President & CEO, Co-Founder. “We also experienced a number of challenges and the biggest of course, was having to overcome the loss of our Chief Medical Officer, Dr. Allen Herman, who died after a brief illness earlier this year. With Allen’s legacy in mind, we are moving ahead very strong, and I believe we have the right team in place to propel our Company forward for decades to come. The Black-tie Gala Awards Celebration will provide an opportunity to reflect on our accomplishments and thank those who have contributed in so many different and important ways.”
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers